Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Mountain Valley MD Holdings Inc C.MVMD

Alternate Symbol(s):  MVMDF

Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural... see more

CSE:MVMD - Post Discussion

Mountain Valley MD Holdings Inc > Animal Husbandry
View:
Post by Highprob on May 12, 2021 10:41pm

Animal Husbandry

MVMD needleless application of solubilized ivermectin delivers 100% in rapid acting intramuscular injections that could be rapidly administered with needleless applicators and the precision control allows for calibration of an adequate withdrawal period in broiler birds and painless safe and less stressful injections in cattle, swine, goats, etc. If you recall, our injectable has an 800% increase in bioavailability so when you start to look at the broad benefits including reduction of the API, MVMD has a significant value proposition that doesn’t exist with the drug today.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities